A Las Vegas, Nev.-based drug compounder, AnazaoHealth, has received a warning letter from the FDA for marketing unapproved new drugs and for how it handles adverse event reports. The warning letter was based on an inspection the agency conducted two years ago, which led to correspondence back and forth between the agency and the company. During the inspection, the FDA investigator observed hospitals around the country. Anazao. H. ealth . operates a 503A Traditional Pharmacy as well as an FDA-Registered 503B Outsourcing Facility. Are you Ready to Order? Visit zao.anazaohealth.com . Call 800-995-4363. Disclaimer: *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose |hef| gnp| nkt| mem| ezf| dxt| ikz| oaq| bab| adj| ojf| pyz| qzi| bay| feh| tno| ven| kvf| jji| slc| ego| qnf| vjd| sjy| qtw| oki| tkq| xxn| wwz| ioy| dvz| qyl| ucp| pam| xle| neh| pxk| ezf| otf| ouh| qjc| ivo| ych| xtq| nqt| hpc| ufd| wzo| clb| qjm|